Developing a highly differentiated R&D pipeline of products is key to the success of any pharmaceutical or biotechnology company. We facilitate portfolio decision making through identification of drivers of value and risk for each project in the portfolio and the development of an unbiased and rigorous trade off methodology to determine when to advance, optimize, partner, or abandon an project to achieve the highest potential value for your investment.